Industry Leaders Unite to Create First-Ever End-to-End Critical Connectivity Ecosystem Showcase at ISE Barcelona 2026 January 16, 2026 Alfalite, Brainstorm, Dejero, Domo Broadcast Systems, FOR-A, KitPlus, Ontario Soluciones and RGB Spectrum partner to demonstrate revolutionary integrated solution "Where Critical Moments Meet Unbreakable Connections"
UK CfD AR7 Results Signal New Realities for Offshore Wind Economics Ahead of AR8 — Aegir Insights January 16, 2026 The UK government yesterday published the results of the highly anticipated Contracts for Difference (CfD) Allocation Round 7 (AR7), highlighting both sustained appetite for UK offshore wind and the growing complexity of delivering competitive, bankable bids. The allocation round awarded a record 8.4 GW of offshore wind capacity across eight projects after the government increased [...]
Morningstar Launches First Pure-Play Generative AI Index January 16, 2026 New perpetual benchmark tracks the performance of pure-play private companies driving GenAI innovation across the corporate lifecycle.
Lone Star Announces Sale of SENQCIA to Noritsu Koki January 16, 2026 Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XI, L.P. has entered into a definitive agreement to sell SENQCIA Corporation (“SENQCIA”), a leading provider of mission-critical building products and solutions in Japan, to Noritsu Koki Co., Ltd., in a transaction that represents a total enterprise value of approximately $519 [...]
Announcement Regarding the Launch of an Open-Ended Aircraft Fund January 16, 2026 – Providing investors with a more liquid aircraft investment opportunity, a new frontier in alternative investments – – The first initiative of its kind by a Japan-based asset manager –
Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema January 16, 2026 Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a potentially promising therapeutic option. LumiNE is part of Almirall’s ongoing lifecycle management activities to enable more patients to benefit from advanced treatments - such as Lebrikizumab - targeting patients with dermatological conditions and high unmet medical needs. The phase III study will be initiated within the first half of 2026 and will evaluate the efficacy, safety, and tolerability of lebrikizumab in at least 270 patients with nummular eczema in Europe for up to 48 weeks of treatment.
Northern Trust Asset Management Forecasts AI-Driven Strength in Private Markets; United States, Japan and Australia to Lead Equity Returns over Next Decade January 16, 2026 AI innovation, the global shift to self-reliance and rising government debt likely to be key drivers of financial markets
Rapyd’s 2026 State of Stablecoins: Businesses Move En Masse as Stablecoins Go Mainstream January 16, 2026 Rapyd’s 2026 State of Stablecoins Report shows 64% of businesses surveyed already use stablecoins or plan to within three years, with speed, easier cross-border transactions, and cost savings driving adoption
Everest Appoints Christopher Kujawa as Executive Vice President and Chief Human Resources Officer January 16, 2026 Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, announced today that Christopher Kujawa has been appointed Executive Vice President and Chief Human Resources Officer, effective January 20, 2026. Mr. Kujawa will report to Jim Williamson, President and CEO and will serve on Everest’s Executive Leadership Team. He [...]
Primient to Acquire Full Ownership of Primient Covation, LLC January 16, 2026 Primient, a global leader in biomanufacturing, announced today it has agreed to purchase the remaining ownership interest in Primient Covation, LLC (“Primient Covation”), establishing Primient as the sole owner of the company and marking an exciting new chapter in Primient’s growth in the bioeconomy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114344080/en/ [...]